Biomarkers predicting response to durvalumab combined with olaparib in the neoadjuvant I-SPY 2 TRIAL for high-risk breast cancerDenise M. Wolf,Christina Yau,Lamorna Brown-Swigart,Nick O'Grady,Gillian Hirst,Laura Sit,Smita Asare,Don Berry,Laura Esserman,Hyo Han,Lajos Pusztai,Laura van 't VeerCANCER RESEARCH(2021)引用 0|浏览25暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要